| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Aminobutanal | N-(3-Aminopropyl)-4-Aminobutanal | VL6270001 | View CAS 136849-70-2 |
| Aminobutanal | 4-(Dimethylamino)butanal | VL6270002 | View CAS 104459-70-3 |
Aminobutanal Impurities
| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Aminobutanal | N-(3-Aminopropyl)-4-Aminobutanal | VL6270001 | View CAS 136849-70-2 |
| Aminobutanal | 4-(Dimethylamino)butanal | VL6270002 | View CAS 104459-70-3 |
[rfq_list]
| Catalogue No. | VL6270002 |
| CAS No. | 104459-70-3 |
| Molecular Formula | C6H13NO |
| Molecular Weight | 115.17 g/mol |
| Parent drug | Aminobutanal |
| IUPAC Name | 4-(dimethylamino)butanal |
| Synonyms | N/A |
| References | Douša, Michal, et al. “Identification, Preparation and UHPLC Determination of Process-Related Impurity in Zolmitriptan.” Journal of Pharmaceutical and Biomedical Analysis, vol. 58, Jan. 2012, pp. 1–6, https://doi.org/10.1016/j.jpba.2011.08.043 Palmer, Katharine J., and Caroline M. Spencer. “Zolmitriptan.” CNS Drugs, vol. 7, no. 6, June 1997, pp. 468–78, https://doi.org/10.2165/00023210-199707060-00005.? |
| Status | In-stock |
| ListName | 4-(Dimethylamino)butanal |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
